Technology Valo Therapeutics Selects Exothera to develop large-scale Oncolytic Adenovirus Manufacturing AIT News Desk Jan 11, 2023 Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, announced it has selected…